Somira Health review
The price is stated as locked while the dose rises, on both plan lengths.
The verdict
Somira Health publishes $189.99 a month for compounded semaglutide and $239.99 for tirzepatide, read September 2026. Quarterly billing lowers those to $136.66 and $221.66. The price is stated as locked during titration.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $189.99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Somira Health sells both molecules by injection. Two billing options exist. The quarterly plan is billed as a single total.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state plans and totals. The clinician is not described.
The titration guarantee is the claim to hold them to. It applies to both plan lengths and it is stated rather than implied.
What happens when the dose goes up?
Price locked as you titrate is the seller's own wording. That answers the dose question directly. Nothing describes clinical support at a step.
What the price includes
Six months month to month is $1,140 on semaglutide. The quarterly plan is $409.99 billed once, or $136.66 a month. Tirzepatide is $664.99 quarterly, $221.66 a month, and fell from $284.99 between readings.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Price stated as locked during titration
- Strength: Quarterly totals published, not just rates
- Strength: Tirzepatide fell $45 between readings
- Limitation: The quarterly plan bills in one charge
- Limitation: No milligram dose published
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Somira Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the rate pinned across an escalation.
- Wrong for
- A reader who needs a monthly charge rather than a quarterly one.
How Somira Health compares
| Seller | Who it suits | Go |
|---|---|---|
 Sunlight | Readers who want a rate guaranteed against increases and will count the fills | See Sunlight → |
| SurpassMD | Readers who will ask what their own approved figure is | See SurpassMD → |
| TeleCareSpot | Readers confident of approval who want a flat all-in rate | See TeleCareSpot → |
More GLP-1 telehealth sellers reviews: Breeze MedsCare Bare RxCoreAge RxStrut HealthSynergy RxActin
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Does the price rise with the dose?
- No. The seller states the price is locked as you titrate.
- What does the quarterly plan cost?
- $409.99 billed once for semaglutide, which is $136.66 a month.
- Has tirzepatide changed?
- Yes. It fell from $284.99 to $239.99 between readings.
- Is Somira Health expensive compared with other GLP-1 telehealth sellers?
- Somira Health publishes a starting figure of $189.99/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Somira Health above the median. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.